Log in

Relevant bibliographies by topics / Boron-neutron capture therapy – Evaluation / Journal articles

To see the other types of publications on this topic, follow the link: Boron-neutron capture therapy – Evaluation.

Journal articles on the topic 'Boron-neutron capture therapy – Evaluation'

Author: Grafiati

Published: 4 June 2021

Last updated: 5 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Boron-neutron capture therapy – Evaluation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

da Silva, A. Filipa F., Raquel S. G. R. Seixas, Artur M. S. Silva, et al. "Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy." Org. Biomol. Chem. 12, no. 28 (2014): 5201–11. http://dx.doi.org/10.1039/c4ob00644e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zaboronok, Alexander, Sergey Taskaev, Olga Volkova, et al. "Gold Nanoparticles Permit In Situ Absorbed Dose Evaluation in Boron Neutron Capture Therapy for Malignant Tumors." Pharmaceutics 13, no. 9 (2021): 1490. http://dx.doi.org/10.3390/pharmaceutics13091490.

Full text

Abstract:

Boron neutron capture therapy (BNCT) is an anticancer modality realized through 10B accumulation in tumor cells, neutron irradiation of the tumor, and decay of boron atoms with the release of alpha-particles and lithium nuclei that damage tumor cell DNA. As high-LET particle release takes place inside tumor cells absorbed dose calculations are difficult, since no essential extracellular energy is emitted. We placed gold nanoparticles inside tumor cells saturated with boron to more accurately measure the absorbed dose. T98G cells accumulated ~50 nm gold nanoparticles (AuNPs, 50 µg gold/mL) and

APA, Harvard, Vancouver, ISO, and other styles

3

Alberti, Diego, Antonio Toppino, Simonetta Geninatti Crich, et al. "Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications." Org. Biomol. Chem. 12, no. 15 (2014): 2457–67. http://dx.doi.org/10.1039/c3ob42414f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Swenson, David H., Brenda H. Laster, and Robert L. Metzger. "Synthesis and Evaluation of a Boronated Nitroimidazole for Boron Neutron Capture Therapy." Journal of Medicinal Chemistry 39, no. 7 (1996): 1540–44. http://dx.doi.org/10.1021/jm950689w.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Vohradsky, James, Susanna Guatelli, Jeremy A. Davis, Linh T. Tran, and Anatoly B. Rosenfeld. "Evaluation of silicon based microdosimetry for Boron Neutron Capture Therapy Quality Assurance." Physica Medica 66 (October 2019): 8–14. http://dx.doi.org/10.1016/j.ejmp.2019.09.072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Mirzaei, Davood, Hashem Miri-Hakimabad, and Laleh Rafat-Motavalli. "Depth dose evaluation for prostate cancer treatment using boron neutron capture therapy." Journal of Radioanalytical and Nuclear Chemistry 302, no. 3 (2014): 1095–101. http://dx.doi.org/10.1007/s10967-014-3397-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bortolussi, S., I. Postuma, N. Protti, et al. "EP-1885 Neutron beam design and dosimetric evaluation for accelerator-based Boron Neutron Capture Therapy." Radiotherapy and Oncology 133 (April 2019): S1024. http://dx.doi.org/10.1016/s0167-8140(19)32305-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Onishi, T., H. Kumada, K. Takada, F. Naito, T. Kurihara, and T. Sakae. "Investigation of the neutron spectrum measurement method for dose evaluation in boron neutron capture therapy." Applied Radiation and Isotopes 140 (October 2018): 5–11. http://dx.doi.org/10.1016/j.apradiso.2018.06.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Takeuchi, Koji, Yoshihide Hattori, Shinji Kawabata, et al. "Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy." Cells 9, no. 6 (2020): 1551. http://dx.doi.org/10.3390/cells9061551.

Full text

Abstract:

Boron neutron capture therapy (BNCT) is a form of tumor-cell selective particle irradiation using low-energy neutron irradiation of boron-10 (10B) to produce high-linear energy transfer (LET) alpha particles and recoiling 7Li nuclei (10B [n, alpha] 7Li) in tumor cells. Therefore, it is important to achieve the selective delivery of large amounts of 10B to tumor cells, with only small amounts of 10B to normal tissues. To develop practical materials utilizing 10B carriers, we designed and synthesized novel dodecaboranethiol (BSH)-containing kojic acid (KA-BSH). In the present study, we evaluated

APA, Harvard, Vancouver, ISO, and other styles

10

Pulagam, Gona, Gómez-Vallejo, et al. "Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation." Molecules 24, no. 19 (2019): 3609. http://dx.doi.org/10.3390/molecules24193609.

Full text

Abstract:

Background: Boron Neutron Capture Therapy (BNCT) is a binary approach to cancer therapy that requires accumulation of boron atoms preferentially in tumour cells. This can be achieved by using nanoparticles as boron carriers and taking advantage of the enhanced permeability and retention (EPR) effect. Here, we present the preparation and characterization of size and shape-tuned gold NPs (AuNPs) stabilised with polyethylene glycol (PEG) and functionalized with the boron-rich anion cobalt bis(dicarbollide), commonly known as COSAN. The resulting NPs were radiolabelled with 124I both at the core a

APA, Harvard, Vancouver, ISO, and other styles

11

Verlinden, B., K. Van Hoecke, A. Aerts, et al. "Quantification of boron in cells for evaluation of drug agents used in boron neutron capture therapy." Journal of Analytical Atomic Spectrometry 36, no. 3 (2021): 598–606. http://dx.doi.org/10.1039/d0ja00456a.

Full text

Abstract:

The combination of UV digestion and nitric acid digestion is an effective sample preparation method for the quantification of boron in cell cultures by ICP-MS in the context of screening BNCT drug candidates for cancer treatment.

APA, Harvard, Vancouver, ISO, and other styles

12

Kasesaz, Yaser, Faezeh Rahmani, and Elham Bavarnegin. "Evaluation of boron neutron capture therapy in-phantom parameters by response matrix method." Journal of Cancer Research and Therapeutics 14, no. 5 (2018): 1065. http://dx.doi.org/10.4103/0973-1482.187288.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Takada, Kenta, Tomonori Isobe, Hiroaki Kumada, et al. "Evaluation of the radiation dose for whole body in boron neutron capture therapy." Progress in Nuclear Science and Technology 4 (2014): 820–23. http://dx.doi.org/10.15669/pnst.4.820.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Soloway, A. H., J. C. Zhuo, F. G. Rong, et al. "Identification, development, synthesis and evaluation of boron-containing nucleosides for neutron capture therapy." Journal of Organometallic Chemistry 581, no. 1-2 (1999): 150–55. http://dx.doi.org/10.1016/s0022-328x(99)00085-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Hattori, Yoshihide, Shintaro Kusaka, Mari Mukumoto, et al. "Biological Evaluation of Dodecaborate-Containing l-Amino Acids for Boron Neutron Capture Therapy." Journal of Medicinal Chemistry 55, no. 15 (2012): 6980–84. http://dx.doi.org/10.1021/jm300749q.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Vorobyeva, Mariya A., Maya A. Dymova, Darya S. Novopashina, et al. "Tumor Cell-Specific 2′-Fluoro RNA Aptamer Conjugated with Closo-Dodecaborate as A Potential Agent for Boron Neutron Capture Therapy." International Journal of Molecular Sciences 22, no. 14 (2021): 7326. http://dx.doi.org/10.3390/ijms22147326.

Full text

Abstract:

Boron neutron capture therapy (BNCT) is a binary radiotherapeutic approach to the treatment of malignant tumors, especially glioblastoma, the most frequent and incurable brain tumor. For successful BNCT, a boron-containing therapeutic agent should provide selective and effective accumulation of 10B isotope inside target cells, which are then destroyed after neutron irradiation. Nucleic acid aptamers look like very prospective candidates for carrying 10B to the tumor cells. This study represents the first example of using 2′-F-RNA aptamer GL44 specific to the human glioblastoma U-87 MG cells as

APA, Harvard, Vancouver, ISO, and other styles

17

Woollard, Jeffrey E., Thomas E. Blue, Nilendu Gupta, and Reinhard A. Gahbauer. "Evaluation of Moderator Assemblies for Use in an Accelerator-Based Neutron Source for Boron Neutron Capture Therapy." Nuclear Technology 123, no. 3 (1998): 320–34. http://dx.doi.org/10.13182/nt98-a2902.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Aizawa, O. "Evaluation of neutron irradiation field for boron neutron capture therapy by using absorbed dose in a phantom." International Journal of Radiation Oncology*Biology*Physics 28, no. 5 (1994): 1143–48. http://dx.doi.org/10.1016/0360-3016(94)90488-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Yanagie, Hironobu, Yosiyuki Sakurai, Koichi Ogura, et al. "Evaluation of neutron dosimetry on pancreatic cancer phantom model for application of intraoperative boron neutron-capture therapy." Biomedicine & Pharmacotherapy 61, no. 8 (2007): 505–14. http://dx.doi.org/10.1016/j.biopha.2006.12.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Kumada, Hiroaki, Kenta Takada, Susumu Tanaka, et al. "Evaluation of the characteristics of the neutron beam of a linac-based neutron source for boron neutron capture therapy." Applied Radiation and Isotopes 165 (November 2020): 109246. http://dx.doi.org/10.1016/j.apradiso.2020.109246.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Isono, Aoi, Mieko Tsuji, Yu Sanada, et al. "Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy." ChemMedChem 14, no. 8 (2019): 823–32. http://dx.doi.org/10.1002/cmdc.201800793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Genady, Afaf R. "Promising carboranylquinazolines for boron neutron capture therapy: Synthesis, characterization, and in vitro toxicity evaluation." European Journal of Medicinal Chemistry 44, no. 1 (2009): 409–16. http://dx.doi.org/10.1016/j.ejmech.2008.02.037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Miura, M., P. L. Micca, C. D. Fisher, C. R. Gordon, J. C. Heinrichs, and D. N. Slatkin. "Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy." British Journal of Radiology 71, no. 847 (1998): 773–81. http://dx.doi.org/10.1259/bjr.71.847.9771389.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kawabata, Shinji, Koji Takeuchi, Ryo Hiramatsu, et al. "RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)." Neuro-Oncology Advances 1, Supplement_2 (2019): ii22. http://dx.doi.org/10.1093/noajnl/vdz039.097.

Full text

Abstract:

Abstract Boron neutron capture therapy (BNCT) is the particle irradiation therapy that the selective radiation for tumor cells is available for theoretically. The role that the amino acid (phenylalanine) PET (18F-BPA-PET) that we used boronophenylalanine (BPA) which is a boron compound for neutron capture reaction as a tracer carries out is major in our BNCT especially for the recent non-craniotomy BNCT, and it covers by treatment, observation from indication. In this report, we introduce this PET as a principal axis about BNCT and a relation of the PET.In our BNCT, we calculated the drug accu

APA, Harvard, Vancouver, ISO, and other styles

25

Kimura, Sadaaki, Shin-ichiro Masunaga, Tomohiro Harada, et al. "Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy." Bioorganic & Medicinal Chemistry 19, no. 5 (2011): 1721–28. http://dx.doi.org/10.1016/j.bmc.2011.01.020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Takada, Kenta, Hiroaki Kumada, Tomonori Isobe, et al. "Whole-body dose evaluation with an adaptive treatment planning system for boron neutron capture therapy." Radiation Protection Dosimetry 167, no. 4 (2014): 584–90. http://dx.doi.org/10.1093/rpd/ncu357.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Al-Madhoun, Ashraf S., Jayaseharan Johnsamuel, Rolf F. Barth, Werner Tjarks, and Staffan Eriksson. "Evaluation of Human Thymidine Kinase 1 Substrates as New Candidates for Boron Neutron Capture Therapy." Cancer Research 64, no. 17 (2004): 6280–86. http://dx.doi.org/10.1158/0008-5472.can-04-0197.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Soloway, A. H., J. C. Zhuo, F. G. Rong, et al. "ChemInform Abstract: Identification, Development, Synthesis, and Evaluation of Boron-Containing Nucleosides for Neutron Capture Therapy." ChemInform 30, no. 35 (2010): no. http://dx.doi.org/10.1002/chin.199935319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Tjarks, W., J. Wang, S. Chandra, et al. "SYNTHESIS AND BIOLOGICAL EVALUATION OF BORONATED NUCLEOSIDES FOR BORON NEUTRON CAPTURE THERAPY (BNCT) OF CANCER." Nucleosides, Nucleotides and Nucleic Acids 20, no. 4-7 (2001): 695–98. http://dx.doi.org/10.1081/ncn-100002353.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Portu, Agustina, Andrés Eugenio Rossini, Silvia Inés Thorp, et al. "Simultaneous Observation of Cells and Nuclear Tracks from the Boron Neutron Capture Reaction by UV-C Sensitization of Polycarbonate." Microscopy and Microanalysis 21, no. 4 (2015): 796–804. http://dx.doi.org/10.1017/s1431927615014348.

Full text

Abstract:

AbstractThe distribution of boron in tissue samples coming from boron neutron capture therapy protocols can be determined through the analysis of its autoradiography image on a nuclear track detector. A more precise knowledge of boron atom location on the microscopic scale can be attained by the observation of nuclear tracks superimposed on the sample image on the detector. A method to produce an “imprint” of cells cultivated on a polycarbonate detector was developed, based on the photodegradation properties of UV-C radiation on this material. Optimal conditions to generate an appropriate mono

APA, Harvard, Vancouver, ISO, and other styles

31

Mangueira, T. F., C. F. Silva, P. R. P. Coelho, and L. L. Campos. "Gamma/neutron dose evaluation using Fricke gel and alanine gel dosimeters to be applied in boron neutron capture therapy." Applied Radiation and Isotopes 68, no. 4-5 (2010): 791–94. http://dx.doi.org/10.1016/j.apradiso.2010.01.027.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

LA, Kuzmanic, Zuidema LE, Elsawa SF*, Takagaki M*, and Hosmane NS*. "Synthesis and Biological Evaluation of Fluorescein-Tagged 1-Methyl-o-carborane for Boron Neutron Capture Therapy." Annals of Advances in Chemistry 2, no. 1 (2018): 075–81. http://dx.doi.org/10.29328/journal.aac.1001016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Renner, M., M. Miura, M. Easson, and M. Vicente. "Recent Progress in the Syntheses and Biological Evaluation of Boronated Porphyrins for Boron Neutron-Capture Therapy." Anti-Cancer Agents in Medicinal Chemistry 6, no. 2 (2006): 145–57. http://dx.doi.org/10.2174/187152006776119135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Morris, G. M., J. A. Coderre, P. L. Micca, M. M. Nawrocky, J. W. Hopewell, and M. Miura. "Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa." Radiation Research 163, no. 1 (2005): 72–78. http://dx.doi.org/10.1667/rr3272.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

El-Zaria, Mohamed E., Afaf R. Genady, and Detlef Gabel. "Azanonaboranes Containing Imidazole Derivatives for Boron Neutron Capture Therapy: Synthesis, Characterization, and In Vitro Toxicity Evaluation." Chemistry - A European Journal 12, no. 31 (2006): 8084–89. http://dx.doi.org/10.1002/chem.200501580.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Morris, G. M., J. A. Coderre, P. L. Micca, D. T. Lombardo, and J. W. Hopewell. "Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage." British Journal of Radiology 73, no. 868 (2000): 429–34. http://dx.doi.org/10.1259/bjr.73.868.10844870.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Morris, G. M., J. A. Coderre, J. W. Hopewell, P. L. Micca, M. Nawrocky, and M. Miura. "Porphyrin-mediated boron neutron capture therapy: evaluation of the reactions of skin and central nervous system." International Journal of Radiation Biology 79, no. 3 (2003): 149–58. http://dx.doi.org/10.1080/0955300031000073392.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Tjarks, Werner, Abul K. M. Anisuzzaman, Liang Liu, et al. "Synthesis and in vitro evaluation of boronated uridine and glucose derivatives for boron neutron capture therapy." Journal of Medicinal Chemistry 35, no. 9 (1992): 1628–33. http://dx.doi.org/10.1021/jm00087a019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Barth, Rolf F., Weilian Yang, and Jeffrey A. Coderre. "Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation." Journal of Neuro-oncology 62, no. 1-2 (2003): 61–74. http://dx.doi.org/10.1007/bf02699934.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Ueda, Hiroki, Minoru Suzuki, Reiko Kuroda, Tomohiro Tanaka, and Shin Aoki. "Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy." Journal of Medicinal Chemistry 64, no. 12 (2021): 8523–44. http://dx.doi.org/10.1021/acs.jmedchem.1c00445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Asano, Ryuji, Amon Nagami, Yuki Fukumoto, et al. "Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer." Bioorganic & Medicinal Chemistry Letters 24, no. 5 (2014): 1339–43. http://dx.doi.org/10.1016/j.bmcl.2014.01.054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Tsurubuchi, Takao, Makoto Shirakawa, Wataru Kurosawa та ін. "Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT". Cells 9, № 5 (2020): 1277. http://dx.doi.org/10.3390/cells9051277.

Full text

Abstract:

Boron neutron capture therapy (BNCT) is a unique anticancer technology that has demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine (BPA) and sodium borocaptate (BSH) used as 10B delivery agents. However, continuous drug administration at high concentrations is needed to maintain sufficient 10B concentration within tumors. To address the issue of 10B accumulation and retention in tumor tissue, we developed MMT1242, a novel boron-containing α-d-mannopyranoside. We evaluated the uptake, intracellular distribution, and retention of MMT1242 in cultured cells a

APA, Harvard, Vancouver, ISO, and other styles

43

Takai, Satoshi, Yoko Matsushita, Shinji Kawabata, et al. "NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET." Neuro-Oncology Advances 2, Supplement_3 (2020): ii13. http://dx.doi.org/10.1093/noajnl/vdaa143.055.

Full text

Abstract:

Abstract We have applied boron neutron capture therapy (BNCT) for 46 recurrent high grade meningiomas (HGM). Twelve cases among them, fluoride-labeled boronophenylalanine positron emission tomography (18F-BPA-PET) were utilized before and after BNCT to evaluate the tumor activity. The lesion to normal brain (L/N) ratios of 14 lesions of these 11 cases were investigated. In all cases L/N ratio decreased after BNCT. The L/N ratio of recurrent (HGM) was 3.2±1.5 (mean±SD) before BNCT and 2.1±0.6 after that. In contrast enhanced MRI, 13 out of 14 lesions shrank or unchanged at least 3 months after

APA, Harvard, Vancouver, ISO, and other styles

44

Byun, Youngjoo, Junhua Yan, Ashraf S. Al-Madhoun, et al. "Synthesis and Biological Evaluation of Neutral and Zwitterionic 3-Carboranyl Thymidine Analogues for Boron Neutron Capture Therapy." Journal of Medicinal Chemistry 48, no. 4 (2005): 1188–98. http://dx.doi.org/10.1021/jm0491896.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Bond, Victor P., Brenda H. Laster, and Lucian Wielopolski. "The Equal Effectiveness Ratio: A Quantitative Approach to the Evaluation of Compounds for Boron Neutron Capture Therapy." Radiation Research 141, no. 3 (1995): 287. http://dx.doi.org/10.2307/3579005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

El-Zaria, Mohamed E. "Crystallographic report: Synthesis and biological evaluation of novel azanonaboranes as potential agents for boron neutron capture therapy." Applied Organometallic Chemistry 19, no. 5 (2005): 683–89. http://dx.doi.org/10.1002/aoc.786.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tjarks, W., and et al et al. "ChemInform Abstract: Synthesis and Biological Evaluation of Boronated Nucleosides for Boron Neutron Capture Therapy (BNCT) of Cancer." ChemInform 32, no. 47 (2010): no. http://dx.doi.org/10.1002/chin.200147223.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Matsumoto, T., and O. Aizawa. "Depth-dose evaluation and optimisation of the irradiation facility for boron neutron capture therapy of brain tumours." Physics in Medicine and Biology 30, no. 9 (1985): 897–907. http://dx.doi.org/10.1088/0031-9155/30/9/002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Guatelli, Susanna, James Vohradsky, Jeremy Davis, Linh T. Tran, and Anatoly Rosenfeld. "Abstract ID: 28 Evaluation of silicon and diamond based microdosimetry for boron neutron capture therapy quality assurance." Physica Medica 42 (October 2017): 4. http://dx.doi.org/10.1016/j.ejmp.2017.09.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

El-Zaria, Mohamed E, Hyun Seung Ban, and Hiroyuki Nakamura. "Boron-Containing Protoporphyrin IX Derivatives and Their Modification for Boron Neutron Capture Therapy: Synthesis, Characterization, and Comparative In Vitro Toxicity Evaluation." Chemistry - A European Journal 16, no. 5 (2010): 1543–52. http://dx.doi.org/10.1002/chem.200901532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!